Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis

Por P. A. Shesternya, O. D. Gritsenko, P. A. Astanin, A. Yu. Stepanenko, N. V. Popov
Publicado em 2021-04-01

DRUG-INDUCED ENCEPHALOPATHY WITH IMPAIRED COGNITIVE FUNCTIONS DURING TOCILIZUMAB USE

Por P. A. Shesternya, S. V. Prokopenko, E. Yu. Mozheiko, O. D. Gritsenko, T. V. Tupaeva, E. M. Kurts
Publicado em 2019-09-01

Features of T lymphocyte subpopulation profile in patients with ankylosing spondylitis undergoing genetically engineered biological therapy

Por A. A. Savchenko, O. D. Gritsenko, A. G. Borisov, I. V. Kudryavtsev, M. K. Serebriakova, A. A. Masterova, P. A. Shesternya
Publicado em 2021-12-01